company

MED24 APOTEK AS

0950 OSLO

Return on Equity
−194,15 %
Current Ratio
0,92
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue6 963 000
Net Income730 000
Total Assets6 040 000
Total Equity−376 000
Income (NOK)2022
Revenue6 963 000
Expenditure5 962 000
Operating Profit1 002 000
Financial Income0
Financial Costs271 000
Financial Balance−271 000
Earnings Before Tax730 000
Tax0
Net Income730 000
Balance (NOK)2022
Total Fixed Assets118 000
Total Current Assets5 922 000
Total Assets6 040 000
Total Retained Equity−406 000
Total Equity−376 000
Total Long-Term Debt0
Total Current Debt6 416 000
Total Equity and Debt6 040 000
Cash flow (NOK)2022
Sales Income6 963 000
Other Income0
Revenue6 963 000
Cost of Goods Sold0
Salary Costs3 325 000
Depreciation16 000
Impairment0
Expenditure5 962 000
Operating Profit1 002 000
Financial Income0
Financial Costs271 000
Financial Balance−271 000
Dividends0
Net Income730 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures65 000
Total Tangible Assets65 000
Total Fiancial Fixed Assets52 000
Total Fixed Assets118 000
Stock3 574 000
Total Investments0
Cash, Bank1 602 000
Total Current Assets5 922 000
Total Assets6 040 000
Total Equity−376 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors3 865 000
Unpaid Taxes2 289 000
Dividends0
Other Current Debt262 000
Total Current Debt6 416 000
Total Equity and Debt6 040 000
Financial indicators2022
Return on Equity−194,15 %
Debt-to-Equity Ratio−0
Operating Profit Margin14,39 %
Current Ratio0,92
Quick Ratio2,08
Equity Ratio−0,06
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English